Related Experiment Video

Updated: Aug 23, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

[Do syndromes X, cardiac and metabolic, have any similar characteristics?]

Wiktoria Leśniak1, Władysława Kolasińska-Kloch

  • 1II Klinika Kardiologii Instytutu Kardiologii Collegium Medicum Uniwersytetu Jagiellońskiego ul. Kopernika 17, 31-501 Kraków.

Folia Medica Cracoviensia
|July 6, 2004
PubMed

Insights

Syndrome X, encompassing cardiac and metabolic conditions, shares hyperinsulinemia and endothelial dysfunction. Gene mutations in nitric oxide synthase may contribute to these syndromes, impacting blood vessel function.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Syndrome
  • Genetics

Background:

  • Two distinct syndromes are referred to as Syndrome X: cardiac Syndrome X and metabolic Syndrome X.
  • Both syndromes are characterized by hyperinsulinemia and endothelial dysfunction.
  • Metabolic Syndrome X is defined by impaired glucose tolerance, insulin resistance, and at least two cardiovascular risk factors.

Purpose of the Study:

  • To investigate the role of endothelial nitric oxide synthase (eNOS) gene mutations in the etiology of both cardiac and metabolic Syndrome X.
  • To explore the mechanisms underlying endothelial dysfunction in these syndromes, including nitric oxide (NO) synthesis and inactivation, and the role of vasoconstricting agents.
  • To examine the direct and hemodynamic effects of insulin on vascular endothelium and smooth muscle cells.

Main Methods:

  • Analysis of endothelial nitric oxide synthase (eNOS) gene mutations.
  • Assessment of endothelial function markers.
  • Evaluation of insulin's effects on vascular cells and hemodynamics.
  • Review of existing literature on Syndrome X, insulin resistance, and endothelial dysfunction.

Main Results:

  • Hyperinsulinemia and endothelial dysfunction are common features of both cardiac and metabolic Syndrome X.
  • Potential mechanisms for endothelial dysfunction include altered nitric oxide (NO) bioavailability and increased vasoconstrictor synthesis.
  • Insulin has direct hypertrophic effects on vascular endothelium and smooth muscle cells, influencing skeletal muscle circulation by stimulating both endothelin-1 (ET-1) and nitric oxide (NO) activity.

Conclusions:

  • Endothelial dysfunction plays a crucial role in the pathophysiology of both cardiac and metabolic Syndrome X.
  • Imbalances in the regulation of nitric oxide (NO) and endothelin-1 (ET-1) may contribute to endothelial dysfunction in Syndrome X.
  • Further research into eNOS gene mutations and insulin's vascular effects is warranted for understanding and managing Syndrome X.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...